Tinea capitis caused by Microsporum canis treated with terbinafine

Tinea capitis is a disease found throughout the world. It frequently affects children and only rarely adults, usually post‐menopausal women. Numerous dermatophytes of the genus Microsporum and Tricophyton can cause tinea capitis and griseofulvin is still today the treatment of choice. To study the effectiveness and tolerability of terbinafine treatment in tinea capitis caused by Microsporum canis we treated 26 patients – 22 children and four women – for a period of 12 weeks. Dosage adopted was 62.5 mg day−1 in patients weighing less than 20 kg, 125 mg day−1 in those weighing between 20 and 40 kg, and 250 mg day−1 in patients weighing more than 40 kg. Clinical and mycological healing was achieved in 22 patients (84.6%), tolerability was excellent and in no cases were side effects or abnormal results in blood chemistry tests observed.

[1]  D. Devliotou-Panagiotidou,et al.  Efficacy and tolerability of 8 weeks’ treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  Ak Gupta,et al.  The efficacy and safety of terbinafine in children , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  O. Ceburkovas,et al.  Oral terbinafine for tinea capitis due to Microsporum canis in children. , 2001, Acta dermato-venereologica.

[4]  L. Nesbitt Treatment of tinea capitis , 2000, International journal of dermatology.

[5]  R. Ballona,et al.  Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. , 2000, Journal of the American Academy of Dermatology.

[6]  M. Pau,et al.  Tinea capitis in children in the district of Cagliari, Italy , 1997, Mycoses.

[7]  V. Dragoš,et al.  Lack of Efficacy of 6‐Week Treatment with Oral Terbinafine for Tinea Capitis Due to Microsporum canis in Children , 1997, Pediatric dermatology.

[8]  B. Krafchik,et al.  The use of oral terbinafine (Lamisil) in children. , 1997, Dermatology.

[9]  M. Pau,et al.  Tinea capitis in adults , 1995, Mycoses.

[10]  B. Elewski Cutaneous mycoses in children , 1996, The British journal of dermatology.

[11]  J. Ring,et al.  Oral terbinafine in tinea capitis in children , 1996, Mycoses.

[12]  C. Gianni,et al.  Tinea capitis in adults , 1995, Mycoses.

[13]  T. Jones Overview of the use of terbinafine (Lamisil®) in children , 1995, The British journal of dermatology.

[14]  P. Hutchinson,et al.  Novel cycle changes in scalp hair are caused by etretinate therapy , 1995, The British journal of dermatology.

[15]  M. Zagula,et al.  Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics , 1995, The British journal of dermatology.

[16]  I. Frieden,et al.  Tinea capitis: epidemiology, diagnosis, treatment, and control. , 1994, Journal of the American Academy of Dermatology.

[17]  K. Halling,et al.  Granuloma annulare in patients with malignant lymphoma: clinicopathologic study of thirteen new cases. , 1994, Journal of the American Academy of Dermatology.

[18]  N. Shear,et al.  Antifungal agents: an overview. Part II. , 1994, Journal of the American Academy of Dermatology.

[19]  N. Shear,et al.  Antifungal agents : an overview. II , 1994 .

[20]  N. Shear,et al.  Antifungal agents: an overview. Part I. , 1994, Journal of the American Academy of Dermatology.